Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehrul Hasnain

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The Lancet. Psychiatry|October 20, 2015
Genetic vulnerability in antipsychotic drug-induced diabetesMehrul Hasnain
The Lancet. Psychiatry|October 11, 2016
Schizophrenia and metabolic dysregulation: shared roots?Mehrul Hasnain
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 13, 2012
A concern about the proposed DSM-V criteria reclassifying cognitive disordersTara A Snelgrove, Mehrul Hasnain
Circulation|July 20, 2011
Letter by Hasnain and Vieweg regarding article, "Myocardial infarction and risk of suicide: a population-based case-control study"Mehrul Hasnain, W Victor R Vieweg
The American Journal of Medicine|October 1, 2008
Acute effects of newer antipsychotic drugs on glucose metabolismMehrul Hasnain, W Victor R Vieweg
The American Journal of Medicine|October 12, 2010
Lower parasympathetic drive, insulin resistance, and depressionMehrul Hasnain, W Victor R Vieweg
The American Journal of Psychiatry|June 7, 2011
Question regarding ziprasidone and QTc interval prolongation in the ZODIAC studyW Victor R Vieweg, Mehrul Hasnain
American Heart Journal|October 12, 2010
Is screening cardiac inpatients for depression really feasible?Mehrul Hasnain, W Victor R Vieweg
Archives of Internal Medicine|December 17, 2009
Antipsychotic drug-associated acute hyperglycemia in elderly diabetic patients: do the drugs explain the hyperglycemia?Mehrul Hasnain, W Victor R Vieweg
Postgraduate Medicine|October 12, 2013
Weight considerations in psychotropic drug prescribing and switchingMehrul Hasnain, W Victor R Vieweg
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The Lancet. Psychiatry|October 20, 2015
Genetic vulnerability in antipsychotic drug-induced diabetesMehrul Hasnain
The Lancet. Psychiatry|October 11, 2016
Schizophrenia and metabolic dysregulation: shared roots?Mehrul Hasnain
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 13, 2012
A concern about the proposed DSM-V criteria reclassifying cognitive disordersTara A Snelgrove, Mehrul Hasnain
Circulation|July 20, 2011
Letter by Hasnain and Vieweg regarding article, "Myocardial infarction and risk of suicide: a population-based case-control study"Mehrul Hasnain, W Victor R Vieweg
The American Journal of Medicine|October 1, 2008
Acute effects of newer antipsychotic drugs on glucose metabolismMehrul Hasnain, W Victor R Vieweg
The American Journal of Medicine|October 12, 2010
Lower parasympathetic drive, insulin resistance, and depressionMehrul Hasnain, W Victor R Vieweg
The American Journal of Psychiatry|June 7, 2011
Question regarding ziprasidone and QTc interval prolongation in the ZODIAC studyW Victor R Vieweg, Mehrul Hasnain
American Heart Journal|October 12, 2010
Is screening cardiac inpatients for depression really feasible?Mehrul Hasnain, W Victor R Vieweg
Archives of Internal Medicine|December 17, 2009
Antipsychotic drug-associated acute hyperglycemia in elderly diabetic patients: do the drugs explain the hyperglycemia?Mehrul Hasnain, W Victor R Vieweg
Postgraduate Medicine|October 12, 2013
Weight considerations in psychotropic drug prescribing and switchingMehrul Hasnain, W Victor R Vieweg
Pageof 5